Pc
PeptideCalc
πŸ”₯Weight ManagementPopular

Semaglutide Reconstitution Calculator

GLP-1 agonist. Titrate 0.25–2.4 mg over 16–20 weeks. Calculate exact BAC water amounts, syringe units, and concentrations with our free calculator below.

Medical Disclaimer

This tool is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider before beginning any peptide protocol. PeptideCalc does not sell, distribute, or endorse any peptides. Users assume full responsibility for their use of this information.

βš—οΈConfigure Dose

GLP-1 agonist. Titrate 0.25–2.4 mg over 16–20 weeks.

πŸ“… Vial Expiry Tracker

πŸ“ŠResults

πŸ§ͺ

Select a peptide and fill in fields.

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management. Known commercially as Ozempic (diabetes) and Wegovy (weight management), it mimics the incretin hormone GLP-1, regulating appetite, insulin secretion, and gastric emptying. In clinical trials, participants lost an average of 15–17% of body weight over 68 weeks at the 2.4 mg maintenance dose.

How to Reconstitute Semaglutide

Lyophilized semaglutide requires reconstitution with bacteriostatic water. Inject the BAC water slowly against the glass wall of the vial β€” never directly onto the powder. Swirl gently until fully dissolved (typically 2–3 minutes). The solution should be clear and colorless; discard if cloudy or contains particles.

Recommended BAC Water by Vial Size

  • 2 mg vial β†’ 1 mL BAC water (2 mg/mL)
  • 3 mg vial β†’ 1 mL BAC water (3 mg/mL)
  • 5 mg vial β†’ 2 mL BAC water (2.5 mg/mL)
  • 10 mg vial β†’ 3 mL BAC water (3.33 mg/mL)

Titration Schedule

Semaglutide requires slow dose escalation over 16–20 weeks to minimize gastrointestinal side effects such as nausea, vomiting, and diarrhea. Rushing this schedule is one of the most common mistakes and significantly increases side effect severity.

  • Weeks 1–4: 0.25 mg weekly (starting dose)
  • Weeks 5–8: 0.5 mg weekly
  • Weeks 9–12: 1.0 mg weekly
  • Weeks 13–16: 1.7 mg weekly
  • Weeks 17+: 2.4 mg weekly (maintenance)

Injection Technique

Semaglutide is administered subcutaneously, typically in the abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy. Inject at the same time each week for consistent blood levels. Allow the alcohol swab to dry completely before injecting β€” wet alcohol stings.

Storage Guidelines

Unreconstituted powder: freezer at βˆ’20Β°C for long-term, or fridge at 2–8Β°C for shorter periods. Once reconstituted: refrigerate at 2–8Β°C and use within 28 days. Never freeze reconstituted solution β€” freeze-thaw cycles break peptide bonds and reduce potency. Protect from light.

Common Side Effects

The most frequently reported side effects include nausea (especially during dose escalation), constipation, diarrhea, and injection site reactions. These typically diminish as the body adjusts. Serious but rare side effects include pancreatitis and gallbladder problems β€” seek medical attention for severe abdominal pain.

This information is for educational and research purposes only. Semaglutide is a prescription medication. Always consult a licensed healthcare provider before beginning any protocol.

πŸ“š References

  1. [1] Wilding JPH et al. β€œOnce-Weekly Semaglutide in Adults with Overweight or Obesity.” N Engl J Med (2021). PMID: 33567185
  2. [2] Marso SP et al. β€œSemaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.” N Engl J Med (2016). PMID: 27633186

Related Weight Management Calculators